IL10 and Miyoshi myopathy: This was associated with increased production of IL-10 and increased expression of T-cell immunoglobulin and immunoreceptor tyrosine-based inhibition motif (ITIM) domains (TIGIT) and PD1 (38), highlighting the importance of early use of checkpoint inhibitions in MM to avoid T-cell exhaustion and provide a long-term immunological control.